Recently, the Pharmaceutical company behind the manufacture of the COVID -19 treatment Verluky has recalled its products. This recall is following the discovery of particles of glass in the vials of a specific batch which was already distributed across the U.S. in July, 2024. If you use Verluky, it is necessary to stay updated on this new development to protect your health and even that of your family.
Which batch of verluky is being recalled?
The recall has affected a lot of Verluky and the lot code is 47035CFA. This lot of Verluky was distributed across America from mid-July, 2024. The company is not doing this alone, the recall is conducted with the cooperation of the U.S. Food and Drug Administration (FDA) to ensure that the public is safe. If you already received a COVID-19 treatment, check the packaging to be sure that it is not in the affected batch. You need to take prompt action as the glass particles found in the vials of the recalled batch can cause serious health complications particularly, if you are already infected by the COVID-19 virus.
Why was the verluky drug recalled?
The Verluky COVID treatment was recalled because of the discovery of glass particles in the vials of the treatment. Health experts have confirmed that glass contamination in the treatment can result in a range of complications such as irritation when injected, and serious health complications if the glass gets to the bloodstream. In some cases, very rare, the glass can cause life threatening blockage in major organs in the body. These are the reasons the recall was done by the manufacturing company to avoid any further damage and serious health complications by users.
Currently, there is no serious health complication reported in relation to the glass contamination. However, it is crucial that if you are using Verluky, you must confirm the Lot Code and be sure it is not the recalled product.
What should you do if you have the recalled verluky?
If you or a loved one has been using Verluky to treat COVID-19, it is essential to act quickly to protect yourself and your loved one. Here are a few things you can do:
- Check your prescription: Look at the packaging of your Verluky to determine if it is part of Lot 47035CFA. If it is, stop using the medication immediately.
- Contact your healthcare provider: Get in touch with your doctor to discuss alternative treatments for COVID-19. They will guide you on the next steps and may recommend an alternate batch or another medication to ensure you receive safe care.
- Return the recalled medication: The FDA has instructed healthcare facilities to stop using this lot and return the product. If you received Verluky through a pharmacy or hospital, they should provide details on how to return the affected vials.
- Report any issues: If you have experienced any side effects from taking Verluky, you can report it through the FDA’s MedWatch Adverse Event Reporting program. The program allows patients and healthcare professionals to submit reports of medication-related issues.
How does this affect COVID-19 treatment?
With COVID-19 cases still active in parts of the country, Verluky has been an essential part of treating severe cases. Approved by the FDA, it has been used to reduce symptoms and speed up recovery in those battling serious infections. This recall comes at a time when health experts are closely monitoring new COVID variants, making safe and effective treatments more crucial than ever.
The glass contamination in Verluky serves as a reminder to stay vigilant, even with trusted medications. Although this issue is being addressed quickly, it’s vital to be informed and take necessary precautions.For those impacted, Gilead Sciences has set up a dedicated helpline to answer any questions about the recall and guide you through the return process.
